Biopharma Science and Business Insights
BioPharm International (biopharminternational.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Media & Entertainment brands, Manufacturing brands, in the 71st percentile of 13133 Healthcare brands.
BioPharm International is a US-based scientific journal and media source serving the biopharmaceutical industry. It provides coverage of scientific research, manufacturing practices, and regulatory issues relevant to biopharmaceutical professionals. The publication connects scientists, manufacturers, regulatory affairs experts, and business leaders with insights on R&D, production, and compliance topics, positioning itself as a specialized and trusted information resource bridging scientific research with practical business and regulatory concerns in the biopharma sector.
| Brand Name | BioPharm International |
|---|---|
| Domain | biopharminternational.com |
| Industry | Healthcare, Media & Entertainment |
| Main Competitors | Pharmaceutical Technology (82/100), Genetic Engineering & Biotechnology News (77/100), BioProcess International, Pharmaceutical Executive (79/100), BioPharma Reporter, Contract Pharma (81/100), Drug Discovery & Development |
Moz Domain Authority 50/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #297,341 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "BioPharm International connects biopharmaceutical professionals with scientific and business insights on biopharma R&D, manufacturing & regulatory issues." (Meta description: 17 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Vercel.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is BioPharm International?", Claude could identify the brand as of October 2026. BioPharm International is a trade publication and online resource covering biopharmaceutical manufacturing, covering topics like formulation, analytical testing, regulatory compliance, and bioprocessing for industry professionals. Best known for Trade journalism and technical content for the biopharmaceutical manufacturing industry.
When asked "Best brands similar to BioPharm International?", Claude would recommend BioPharm International as of October 2026. It's a respected industry publication often cited alongside other pharma trade media when discussing sources for biopharma manufacturing news and technical insight.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
BioPharm International's main competitors in Healthcare: Pharmaceutical Technology (82/100), Genetic Engineering & Biotechnology News (77/100), Pharmaceutical Executive (79/100), Contract Pharma (81/100).
Sources: Brand Analyzer scan
BioPharm International has limited AI-search visibility, scoring 41/100 on Brand Analyzer's AI visibility composite (visibility 18, trust 59, recommendation 59). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: BioPharm International official site
BioPharm International scores 59/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: BioPharm International official site
BioPharm International is a US-based scientific journal and media platform focused on the biopharmaceutical industry. It functions as a trade publication delivering news, analysis, and insights on biopharma research, manufacturing, and regulatory topics to industry professionals.
Sources: BioPharm International official site
BioPharm International connects biopharmaceutical professionals with scientific and business insights related to R&D, manufacturing, and regulatory issues. It publishes content that bridges scientific research with practical business and compliance considerations relevant to the biopharmaceutical industry.
Sources: BioPharm International official site
BioPharm International can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: BioPharm International official site
BioPharm International offers published content in the form of a scientific journal and media platform, including articles, analysis, and insights covering biopharmaceutical R&D, manufacturing practices, and regulatory compliance issues.
Sources: BioPharm International official site
BioPharm International is used by biopharmaceutical industry professionals, including scientists, manufacturers, regulatory affairs experts, and business leaders involved in drug development and production.
Sources: BioPharm International official site
BioPharm International is known for providing authoritative, in-depth coverage of biopharmaceutical science, manufacturing processes, and regulatory trends. It serves as a specialized media source trusted by professionals seeking to stay informed on developments in drug development and production.
Sources: BioPharm International official site
BioPharm International scores 41/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
BioPharm International has a limited AI-visibility profile at 41/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (59/100) and its weakest is visibility (18/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #297,341 (Tranco) and a Moz Domain Authority of 50/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data. In a live check, Claude could already identify BioPharm International from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to BioPharm International: Biologique Recherche (80/100), Biobeat (80/100), bit.bio (80/100), Bookem (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.